Expert Ratings for Alimera Sciences
Portfolio Pulse from Benzinga Insights
In the last quarter, Alimera Sciences (NASDAQ:ALIM) received 5 bullish analyst ratings with an average 12-month price target of $7.2, a 6.67% increase over the past month.

June 12, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alimera Sciences received 5 bullish analyst ratings in the last quarter, with an average 12-month price target of $7.2, indicating a positive outlook for the stock.
The 5 bullish analyst ratings for Alimera Sciences in the last quarter indicate a positive sentiment towards the stock. The average 12-month price target of $7.2, which has increased by 6.67% over the past month, suggests that analysts expect the stock price to rise in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100